NIGHTSTARX LIMITED Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- NIGHTSTARX LIMITED's estimated annual revenue is currently $13.7M per year.
- NIGHTSTARX LIMITED's estimated revenue per employee is $201,000
- NIGHTSTARX LIMITED has 68 Employees.
- NIGHTSTARX LIMITED grew their employee count by 45% last year.
- NIGHTSTARX LIMITED currently has 1 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Online Review||Pricing|
What Is NIGHTSTARX LIMITED?
Nightstar Therapeutics plc (NASDAQ: NITE) is a leading clinical-stage gene therapy company focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases including choroideremia, X-linked retinitis pigmentosa and Best vitelliform macular dystrophy.keywords:N/A
Number of Employees
Employee Growth %
NIGHTSTARX LIMITED News
Under the SME Scheme, our principal research subsidiary company, NightstaRx Limited, may be eligible to surrender the trading losses that
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding||Online Review||Pricing|